Table 2. Clinical Characteristics of Brain Tumor Survivors.
N | % | pa | |
---|---|---|---|
Tumor Diagnosis | |||
Ependymoma | 21 | 47 | 0.09 |
Low Grade Glioma | 9 | 20 | |
Craniopharyngioma | 15 | 33 | |
Tumor Location | |||
Infratentorial | 20 | 44 | 0.46 |
Supratentorial | 25 | 56 | |
Pre-CRT Chemotherapy | |||
No | 39 | 87 | <0.01 |
Yes | 6 | 13 | |
Extent of Surgical Resectionb | |||
Biopsy/STR | 21 | 47 | 0.66 |
NTR/GTR | 24 | 53 | |
Hydrocephalus | |||
No | 19 | 42 | 0.30 |
Yes | 26 | 58 | |
CSF Shunting | |||
No | 27 | 60 | 0.18 |
Yes | 18 | 40 |
P-value indicates whether group is equally distributed across sub-categories using Chi-square.
Biopsy= tumor sampling to establish histologic diagnosis without intent to resect; STR= subtotal resection, incomplete tumor resection with gross residual disease present on post-operative neuroimaging; NTR= near total resection, incomplete tumor resection with minimal residual disease present on post-operative neuroimaging; GTR= gross total resection, resection of tumor without apparent gross residual disease observed by the operating neurosurgeon and confirmed on post-operative neuroimaging